Implantation Of Transcatheter Aortic Valve Prosthesis Through The Ascending Aorta Concomitant With Coronary Artery Bypass Grafting Without Cardiopulmonary Bypass. by Leal, João Carlos Ferreira et al.
650
Rev Bras Cir Cardiovasc | Braz J Cardiovasc Surg
Rev Bras Cir Cardiovasc 2014;29(4):650-3Leal JCF, et al. - Implantation of transcatheter aortic valve prosthesis through 
the ascending aorta concomitant with coronary artery bypass grafting without 
cardiopulmonary bypass
RBCCV 44205-1601DOI: 10.5935/1678-9741.20140117
Implantation of transcatheter aortic valve 
prosthesis through the ascending aorta 
concomitant with coronary artery bypass grafting 
without cardiopulmonary bypass
Implante de prótese valvar aórtica transcateter através da aorta ascendente concomitante com 
revascularização do miocárdio sem circulação extracorpórea
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HOW TO DO IT
Abstract
Introduction: The transcatheter aortic valve implantation 
in the treatment of high-risk symptomatic aortic stenosis has 
increased the number of implants every year. The learning curve 
for transcatheter aortic valve implantation has improved since 
the last 12 years, allowing access alternatives.
Objective: The aim of this study is to approach the implan-
tation of transcatheter aortic valve through transaortic via 
associated with off-pump cardiopulmonary bypass surgery in a 
67-year-old man, with chronic obstructive pulmonary disease, 
arterial hypertension and kidney transplant. 
Methods: Off-pump coronary artery bypass surgery was per-
formed and the valve in the aortic position was released successfully. 
Results: There were no complications in the intraoperative 
and postoperative period. Gradient reduction, effective orifice in-
creasing of the prosthesis and absence of valvular regurgitation after 
implantation were observed by transesophageal echocardiography. 
Conclusion: Procedural success demonstrates that implan-
tation of transcatheter aortic valve through the ascending aorta 
associated with coronary artery bypass surgery without CPB is 
a new option for these patients.
Descriptors: Thoracic Aorta. Aortic valve stenosis. Valve Pros-
thesis Implantation. Cardiopulmonary bypass, Coronary artery 
bypass grafting, Systemic inflammatory response syndrome.
Resumo
Introdução: O implante de prótese aórtica transcateter no 
tratamento da estenose aórtica sintomática de alto risco vem 
aumentando de número a cada ano no mundo. A curva de apren-
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mmHg aortic valve, ejection fraction of 80%, left ventricular 
end diastolic diameter (LVEDD) of 51 mm, left atrium and 
aorta of 46 mm and 31 mm, respectively. The creatinine was 
2.8 mg/dl and creatinine clearance of 58 ml plasma/min/m2. 
Other comorbidities included left carotid disease with signif-
icant asymptomatic atherosclerotic plaque. The EuroSCORE 
II was 14.86%. CABG and implantation of transcatheter aortic 
prosthesis for ascending aorta without the use of CPB (Figures 
1 and 2) were performed. Both internal thoracic arteries were 
dissected and a segment of the magna right saphenous vein was 
removed.  The CPB circuit was installed by the vein and fem-
oral artery in case of any complication during the procedure. 
Abbreviations, acronyms & symbols
CABG Coronary Artery Bypass Grafting
CCS 3 Canadian Cardiovascular Society Angina 
Classification
COPD Chronic obstructive pulmonary disease 
CPB Cardiopulmonary by-pass
LVEDD Left ventricular end diastolic diameter
NYHA New York Heart Association
TEE Transesophageal echocardiography
INTRODUCTION
 
The learning curve for transcatheter aortic prosthesis im-
plantation over the last 12 years has improved the results and 
allowed the emergence of other approach vias as implant al-
ternatives. Access through the ascending aorta is a possibil-
ity for cases in which the transfemoral and transapical vias 
are contraindicated, mainly in combined procedures of aor-
tic valve replacement and coronary artery bypass grafting. 
This study describes the implantation of a transcatheter aor-
tic prosthesis through the ascending aorta concomitant with 
coronary artery bypass grafting without cardiopulmonary 
bypass in high risk patients.
METHODS
Operative sequence
67-years-old male patient, white, with chronic obstructive 
pulmonary disease (COPD), hypertension and right kidney 
transplanted seven years ago, was admitted to our hospital 
with angina pectoris, CCS 3 (Canadian Cardiovascular Society 
Angina Classification) and dyspnea at minimum effort, NYHA 
Class IV (New York Heart Association). 
Arterial blood pressure of 150x90 mmHg, heart rate 98 
bpm, cardiac auscultation with presence of an ejection murmur 
in the aortic area, presence of Gallavardin phenomenon[1] and 
B1 hypophonetic sound. Coronary angiography showed crit-
ical obstructive lesions of 80% in the distal third of the right 
coronary anterior descending artery with 70% in the proximal 
third, 99% diagonalis in the proximal third and 80% in the 
first marginal branch ostium. 
A transthoracic echocardiogram (TTE) showed a double 
aortic valve lesion with predominant severe and calcified 
stenosis. The flow rate was 4.44 m/s, mean gradient of 48 
dizado para implante da prótese aórtica transcateter melhorou 
os resultados ao longo dos últimos 12 anos, o que permitiu o 
surgimento de outras vias de acesso como alternativas.
Objetivo: Este trabalho refere-se ao implante de prótese aórti-
ca transcateter pela via transaórtica associada à revascularização 
do miocárdio sem  em paciente do sexo masculino de 67 anos 
com doença pulmonar obstrutiva crônica, hipertensão arterial 
sistêmica e transplante de rim. 
Métodos: A revascularização miocárdica e o implante da 
prótese aórtica transcateter foram realizados com sucesso sem 
o auxílio da circulação extracorpórea. 
Resultados: No intra e pós-operatório não houve complica-
ções, a redução do gradiente transvalvar, o aumento do orifício 
efetivo e ausência de regurgitação paravalvar foram observados 
pelo ecocardiograma transesofágico. 
Conclusão: O implante da prótese aórtica transcateter pela 
aorta ascendente associado com revascularização do miocárdio 
sem circulação extracorpórea é uma nova alternativa para pa-
cientes de alto rico.
Descritores: Aorta torácica. Estenose da valva aórtica. Implante 
de Prótese de Valva. Circulação extracorpórea. Revascularização 
do miocárdio. Síndrome da resposta inflamatória sistêmica.
Fig. 1 – Image of the procedure.
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The procedure was performed in a hybrid operating room 
with C-shaped arch Philips BV Pulsera and transesophageal 
echocardiography (TEE) GE Vivid E9 3D. The response curve 
dose of systemic heparin, described by Bull and colleagues in 
1975 was used[2]. The right internal thoracic artery was anas-
tomosed to the left internal thoracic artery, making a Y-shaped 
branch. Thus, the left internal thoracic artery was grafted to 
the descending artery and the right internal thoracic artery to 
the diagonal branch, and the saphenous vein segment to the 
first marginal branch. CPB was not used at any stage of the 
procedure. 
During the anastomoses of coronary grafts we used 
stabilizer and intracoronary shunts of 1.5 for diagonal and 
1.75 for anterior descending and first marginal branch. In 
the anastomosis of the saphenous marginal branch there was 
a hemodynamic instability due to the presence of cardiac 
dislocation and severe aortic stenosis, by releasing the heart 
to hemodynamic stability, then resumed the anastomoses 
without instability. The implantation of transcatheter aortic 
valve prosthesis was performed through the ascending aorta 
in the anterior, superior and lateral wall, locations with lower 
prevalence of calcification[3]. 
To prevent bleeding a purse was performed using 4.0 
prolene wires and bovine pericardial pledges. The prosthesis 
used was No. 24 and the 28 balloon catheter, the implantation 
in the aortic valve annulus without pre-dilatation guided the 
previously introduced guidewire into the left ventricle. Heart 
rate was increased to 160 bpm using a temporary pacing elec-
trode in the right ventricle, this maneuver was used to decrease 
blood flow in the aorta during the release of the prosthesis and 
the total time of the aortic procedure lasted 28 minutes.
There was no intraoperative and postoperative complica-
tion, the patient was extubated eight hours after the procedure 
without the need for inotropic support or temporary pacemaker. 
Postoperative TEE showed reduced transvalvular gradient, 
effective increased orifice, and absence of paravalvular re-
gurgitation. The patient was asymptomatic and returned to 
professional activity after three months follow-up.
DISCUSSION
The implantation of transcatheter aortic prosthesis rep-
resents a paradigm shift in the treatment of aortic stenosis 
in symptomatic or high risk patients considered inoperable.
The first implantation of transcatheter aortic prosthesis 
in humans was published in 2002[4], and the first randomized 
study to determine safety and effectiveness of transcatheter 
prosthesis in the aortic position demonstrated the noninferior-
ity of the method compared with conventional surgery[5]. The 
global sample exceeded 100 thousand cases of transcatheter 
prostheses implantation over the last twelve years. In Brazil, 
three types of transcatheter prostheses are used, including a 
Brazilian prosthesis with good results through transapical 
access[6] and as an alternative it was implemented by femoral 
access with success[7].
Transapical and transfemoral approaches are the most 
used for the transcatheter treatment of symptomatic calcified 
aortic stenosis. However, in patients with peripheral arteri-
al disease, deformed chest and fragile left ventricular apical 
segment, other approaches can be used. The transaortic ap-
proach through the ascending aorta and ministernotomy is 
an attractive therapeutic option[8]. However, there are few 
reports in the literature on thoracotomy through a median 
sternotomy involving implantation of transcatheter aortic 
prosthesis concomitant to off-pump coronary artery bypass 
grafting. The study by Mohammad et al.[9] in 2011 on the 
transcatheter aortic prosthesis implantation through the as-
cending aorta and coronary artery bypass grafting showed 
reproducible results with success.
Our study concerns a patient who had severe aortic stenosis 
and associated coronary artery disease, and the “Heart Team” 
opted for transaortic via in the ascending portion with full 
median sternotomy due to the need for CABG; two mammary 
arteries and one great saphenous vein segment were used. The 
aid of 3D TEE allowed the release of INOVARE® transcatheter 
aortic prosthesis at the desired location without complication. 
Full off-pump CABG was performed, and the right coronary 
artery was not revascularized because it presented an obstruc-
tive lesion in the distal third. The CPB system was on standby, 
allowing to perform the procedure safely if there were any 
complications. 
However, there were some difficulties during the proce-
dure, the largest of which was to establish the optimal length 
of the introducer and release device of the transcatheter valve 
between puncture in the aortic wall up to the aortic valve an-
nulus. Leaving the guidewire until the tip of the left ventricle 
Fig. 2 – Intraoperative 3D Transesophageal Echocardiogram.
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and determine the exact point of release of the prosthesis are 
important maneuvers to the aforementioned procedure.
The hybrid operative treatment with transcatheter aortic 
prosthesis implantation through the ascending aorta and 
CABG is an alternative therapy that justifies the indication for 
symptomatic calcified aortic stenosis associated with coronary 
artery disease in high-risk patients.
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